BioSpace News Archive

Mettler Toledo Release: November Conference Will Explore Revolutionary Fast Scanning Calorimetry Technique, With Optional Hands-On Training

METTLER TOLEDO is pleased to announce the dates of its 2017 conference exploring Flash DSC technology.

October 18, 2017

·

2 min read

Policy

Myriad’s BRACAnalysis CDx Supplementary PMA Accepted by FDA for Review as a Companion Diagnostic for Lynparza (olaparib) in Metastatic Breast Cancer

The company expects fda priority review to conclude in the fiscal third-quarter 2018.

October 18, 2017

·

9 min read

Drug Development

Loxo Oncology Announces Positive Top-Line Results from Independent Review Committee Assessment of Larotrectinib Dataset

The full dataset is being reserved for a future publication.

October 18, 2017

·

6 min read

Business

Relievant Medsystems Names Ray M. Baker, M.D. as Chief Medical Officer

Dr. Baker will be an integral part of the executive team at Relievant, guiding technology development, clinical research strategy, and commercial initiatives.

October 18, 2017

·

3 min read

Business

The Foundation for Women’s Cancer and TESARO Announce 2nd Year of Partnership Supporting the National Race to End Women’s Cancer

TESARO is the Presenting Break-Through Sponsor of the 8th annual National Race to End Women’s Cancer.

October 18, 2017

·

2 min read

Deals

Optinose Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares of Common Stock

Optinose announced the closing of its initial public offering of 8,625,000 shares of common stock at a public offering price of $16.00 per share.

October 18, 2017

·

3 min read

Biotech Beach

Prometheus Laboratories Release: New Test Monitors Therapeutic Ustekinumab Levels In IBD Patients

Prometheus Laboratories Inc. announces a new therapeutic drug monitoring test for use in adult inflammatory bowel disease (IBD) patients treated with Stelara (ustekinumab).

October 18, 2017

·

2 min read

Business

Momenta Pharmaceuticals Announces Date of Third Quarter 2017 Financial Results Conference Call and Webcast

Management will host a conference call on that date at 10:00 a.m. EDT to discuss these results and provide an update on the company.

October 18, 2017

·

1 min read

Drug Development

Mutabilis Joins The European ENABLE Consortium To Fight Antibiotic Resistance

Mutabilis announces its selection by the European ENABLE project (European Gram-negative Antibacterial Engine), which aims to improve the development of antibiotics against infections caused by multiresistant Gram-negative bacteria.

October 18, 2017

·

5 min read

Pharm Country

Qosina Announces Donation To Puerto Rico For Hurricane Relief Efforts

Qosina, a leading global supplier of stock components to the medical OEM and pharmaceutical industries, today announced that it has donated funds to aid in the relief efforts of hurricane-ravaged Puerto Rico.

October 18, 2017

·

1 min read